BioViva USA Inc™
  • HOME
  • OUR TEAM
  • Invest
  • Intellectual Property
  • Ethos
  • Contact us
BioViva USA Inc™
  • HOME/
  • OUR TEAM/
  • Invest/
  • Intellectual Property /
  • Ethos/
  • Contact us/
blog-banner-min.png
BioViva USA Inc™

The Cure is in the Helix of Humanity

Blog

Press releases, updates and original articles

BioViva USA Inc™
  • HOME/
  • OUR TEAM/
  • Invest/
  • Intellectual Property /
  • Ethos/
  • Contact us/
January 30, 2018

Gene Therapy using anti-inflammatory cytokines promising against MS

January 30, 2018/ Liz Parrish
Astrocyte5.jpg

 BioViva scientist Ali Fallah and his team work on novel gene therapy using anti-inflammatory cytokines and show that these can be a promising approach against multiple sclerosis (MS). 

Source:  Cell Journal.

 

January 30, 2018/ Liz Parrish/ Comment

Liz Parrish

  • What’s All The Buzz? BioViva’s ...
  • Source of stem cells that are ...

We are leaders in gene therapy innovation, developing advanced platforms designed to address severe genetic disorders and the underlying mechanisms of cellular aging.

Join Our Newsletter

Thank you!

©2026. BioViva All rights reserved | For any inquires, contact info@bioviva-science.com